41 – 50 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
-
Mark
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
(
- Contribution to journal › Article
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
(
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2 (hK2) in prostate cancer: Clinical and Methodological studies
2000)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
(
- Contribution to journal › Article
-
Mark
Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen
(
- Contribution to journal › Article